Home / Business and Economy / Aroa Biosurgery's Shareholder Landscape: Individuals Dominate, Institutions Gain Ground

Aroa Biosurgery's Shareholder Landscape: Individuals Dominate, Institutions Gain Ground

Summary

  • Individual investors hold 42% of Aroa Biosurgery shares
  • Institutional investors own 32% of the company
  • CEO Brian Ward is the largest shareholder with 9.6% stake
Aroa Biosurgery's Shareholder Landscape: Individuals Dominate, Institutions Gain Ground

According to the latest analysis as of November 16, 2025, individual investors currently hold the largest stake in Aroa Biosurgery, owning around 42% of the company's shares. In contrast, institutional investors have a 32% ownership in the firm.

The analysis also reveals that the company's CEO, Brian Ward, is the single largest shareholder, holding 9.6% of Aroa Biosurgery's outstanding shares. The second and third largest shareholders are Acorn Capital Limited and Harbour Asset Management Limited, each with a 7.6% stake.

Interestingly, the top 11 shareholders control a combined 51% of the company, suggesting that no individual investor or group has a majority interest in Aroa Biosurgery. This diverse ownership structure indicates that the company has attracted a range of investors, both institutional and individual, who see potential in its future growth and performance.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Aroa Biosurgery's CEO Brian Ward is the largest shareholder, holding 9.6% of the company's shares.
Institutional investors currently own 32% of Aroa Biosurgery's shares.
The top 11 shareholders control 51% of Aroa Biosurgery's ownership.

Read more news on